Recently, the vaccine which is currently developing jointly by Oxford University and AstraZeneca has received a green signal from the vaccine experts.
The Committee of Vaccine Experts approved the Covshield vaccine for emergency use in the country. For the distribution, it needs to get approval from the Drug Controller General of India (DCGI).
Recently, it received approval by a Subject Expert Committee (SEC) of DCGI.
Serum, the country’s largest vaccine maker in India, is preparing 30 crore vaccine doses for distribution.
The serum has already announced that India needs only 10 crore doses. AstraZeneca claims that their vaccine has the ability to withstand even the new corona strain.